Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Fisher Biosciences
Biosciences company adds Cellomics technologies for cellular screening
October 9th, 2005
With the addition of Cellomics, Inc., Fisher Biosciences, a developer and manufacturer of products for life-science research and biopharmaceutical production, is providing cellular-imaging tools that accelerate the drug-discovery process. The addition of Cellomics expands Fisher Biosciences' reach into the high-content cellular-analysis field, where Cellomics is a market leader. Some of the products that Cellomics offers include imaging systems for visualizing cellular activities, fluorescent and other high-content assays, and software applications to facilitate the interpretation of cell-screening assays. High-content screening accelerates the...
Source: Managed Care Law Weekly (2005-10-09)
|
